Sanders Morris Harris Inc. raised its position in shares of Johnson & Johnson (NYSE:JNJ) by 5.3% during the first quarter, Holdings Channel reports. The institutional investor owned 7,950 shares of the company’s stock after buying an additional 400 shares during the period. Sanders Morris Harris Inc.’s holdings in Johnson & Johnson were worth $990,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Gemmer Asset Management LLC increased its position in Johnson & Johnson by 32.5% in the first quarter. Gemmer Asset Management LLC now owns 7,186 shares of the company’s stock worth $895,000 after buying an additional 1,764 shares in the last quarter. Round Table Services LLC increased its position in Johnson & Johnson by 7.3% in the first quarter. Round Table Services LLC now owns 4,782 shares of the company’s stock worth $596,000 after buying an additional 324 shares in the last quarter. Johanson Financial Advisors Inc. acquired a new position in Johnson & Johnson during the first quarter worth about $1,333,000. Boys Arnold & Co. Inc. increased its position in Johnson & Johnson by 1.5% in the first quarter. Boys Arnold & Co. Inc. now owns 88,721 shares of the company’s stock worth $11,050,000 after buying an additional 1,277 shares in the last quarter. Finally, Beech Hill Advisors Inc. increased its position in Johnson & Johnson by 1.3% in the first quarter. Beech Hill Advisors Inc. now owns 33,350 shares of the company’s stock worth $4,154,000 after buying an additional 425 shares in the last quarter. Hedge funds and other institutional investors own 66.02% of the company’s stock.

Johnson & Johnson (NYSE:JNJ) opened at 132.15 on Tuesday. The company’s 50-day moving average is $130.42 and its 200-day moving average is $122.68. The firm has a market capitalization of $355.99 billion, a price-to-earnings ratio of 22.21 and a beta of 0.78. Johnson & Johnson has a 52-week low of $109.32 and a 52-week high of $137.00.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, April 18th. The company reported $1.83 EPS for the quarter, beating the Zacks’ consensus estimate of $1.77 by $0.06. The firm had revenue of $17.77 billion for the quarter, compared to analysts’ expectations of $18.02 billion. Johnson & Johnson had a net margin of 22.87% and a return on equity of 26.50%. The firm’s revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.68 EPS. Equities analysts predict that Johnson & Johnson will post $7.10 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Tuesday, August 29th will be paid a $0.84 dividend. The ex-dividend date of this dividend is Friday, August 25th. This represents a $3.36 dividend on an annualized basis and a yield of 2.54%. Johnson & Johnson’s payout ratio is 56.47%.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.dailypolitical.com/2017/07/18/johnson-johnson-nysejnj-stake-raised-by-sanders-morris-harris-inc.html.

A number of equities research analysts recently commented on JNJ shares. Jefferies Group LLC reissued a “hold” rating and set a $145.00 target price (up previously from $140.00) on shares of Johnson & Johnson in a research report on Friday. Royal Bank Of Canada reissued a “buy” rating and set a $138.00 target price on shares of Johnson & Johnson in a research report on Wednesday, July 12th. BidaskClub cut shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research report on Wednesday, July 12th. Wells Fargo & Company reissued a “market perform” rating and set a $135.00 target price (up previously from $132.00) on shares of Johnson & Johnson in a research report on Thursday, July 6th. Finally, Morgan Stanley increased their target price on shares of Johnson & Johnson from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Wednesday, July 5th. Eleven analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $133.65.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.